Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

$780m Sydney Biomedical Accelerator gains its founding Executive Director

Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...

Portable point-of-care test detects four common STIs in under an hour

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom partner on investor-focused life sciences programs

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

Content from other channels on our network

Data centres must face strict rules on energy and water, says ACF

Recycling facilities certification open for comment

Electrification can protect against global disruption, says EEC

Irrigation upgrade automates NT research station

New fund drives waste sector innovation

Queensland and CSIRO launch free program to help SMEs innovate

Monash research explores safer, smarter human‍-‍robot teamwork

ARENA awards $13m for industrial decarbonisation

NVIDIA working with global robotics companies on physical AI

Physical AI set to transform industrial operations: report

Ahpra launches the National Scheme Strategy 2031

The Agency establishes National Clinical Governance Committee for Digital Health

'No evidence' of medicinal cannabis effectiveness treating anxiety, depression or PTSD

COVID-19 training fail lands residential aged care provider $150K fine

AdPha partners with Therapeutic Guidelines to deliver obesity clinical guidance